{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:57:33Z","timestamp":1792015053232,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>A recent systematic review concluded that critically ill pediatric patients have higher odds of vancomycin-related nephrotoxicity [odds ratio (OR): 3.61, 95% CI: 1.21\u201310.74]. We aimed to assess the incidence and risk factors for vancomycin-associated nephrotoxicity in critically ill children without preexisting renal injury.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A cohort of children admitted to a pediatric intensive care unit, from 2011 to 2016 treated with vancomycin without preexisting renal injury. The main diagnosis, therapeutic interventions and medications administered in this period were evaluated. Generalized estimating equation models were used to assess the association between clinical covariates and the dependent variable pediatric risk, injury, failure, loss, end-stage renal disease (pRIFLE).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Hundred ten patients, representing 1177 vancomycin days, were analyzed. Vancomycin-associated nephrotoxicity was seen in 11.8%. In a multivariate model, higher vancomycin doses were not associated with poorer renal function (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08). Higher serum vancomycin levels were weakly associated with pRIFLE classification (OR: 1.05, 95% CI: 1.02\u20131.07). Furosemide or amphotericin B in addition to the vancomycin treatment was associated with impaired renal function (OR: 2.56, 95% CI: 1.38\u20134.8 and OR: 7.7 95% CI: 2.55\u201323, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Vancomycin-associated nephrotoxicity in acute ill children without preexisting renal injury, measured with pRIFLE, is close to 11.8%. Furosemide and amphotericin B in addition to the vancomycin treatment are strong predictors of worse pRIFLE scores. The influence of acute kidney injury status at pediatric intensive care unit admission and the method used for renal function assessment might influence the incidence of vancomycin-associated nephrotoxicity and its associated risk factors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002391","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T08:49:44Z","timestamp":1561020584000},"page":"934-938","source":"Crossref","is-referenced-by-count":21,"title":["Vancomycin-associated Nephrotoxicity and Risk Factors in Critically Ill Children Without Preexisting Renal Injury"],"prefix":"10.1097","volume":"38","author":[{"given":"Helen dos Santos","family":"Feiten","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Miyake","family":"Okumura","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Kohut","family":"Martinbiancho","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinara","family":"Andreolio","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta\u00eds Sica","family":"da Rocha","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Roberto","family":"Antonacci Carvalho","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Pedro Piva","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-20230912","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment.","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jpids\/pit076","article-title":"Are elevated vancomycin serum trough concentrations achieved within the first 7 days of therapy associated with acute kidney injury in children?","volume":"3","author":"Knoderer","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/jpids\/piu110","article-title":"Pharmacodynamic characteristics of nephrotoxicity associated with vancomycin use in children.","volume":"4","author":"Le","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2146\/ajhp120072","article-title":"Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.","volume":"69","author":"McKamy","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/hpeds.2014-0019","article-title":"Evaluation of vancomycin dosing and corresponding drug concentrations in pediatric patients.","volume":"4","author":"Geerlof","year":"2014","journal-title":"Hosp Pediatr"},{"key":"R6-20230912","first-page":"486","article-title":"Frequency of and risk factors for acute kidney injury associated with vancomycin use in the pediatric intensive care unit.","volume":"21","author":"Bonazza","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/phar.1227","article-title":"Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 \u03bcg\/ml in a pediatric intensive care unit.","volume":"33","author":"Cies","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/phar.1259","article-title":"Acute kidney injury during vancomycin therapy in critically ill children.","volume":"33","author":"Totapally","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R9-20230912","first-page":"332","article-title":"Does combination therapy with vancomycin and piperacillin-tazobactam increase the risk of nephrotoxicity versus vancomycin alone in pediatric patients?","volume":"21","author":"McQueen","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis.","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/INF.0000000000001882","article-title":"Nephrotoxicity with vancomycin in the pediatric population: a systematic review and meta-analysis.","volume":"37","author":"Fiorito","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.ki.5002231","article-title":"Modified RIFLE criteria in critically ill children with acute kidney injury.","volume":"71","author":"Akcan-Arikan","year":"2007","journal-title":"Kidney Int"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults.","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N Engl J Med"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-015-3180-9","article-title":"Drugs as risk factors of acute kidney injury in critically ill children.","volume":"31","author":"Glanzmann","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/20469047.2015.1120409","article-title":"Incidence, risk factors and outcome of acute kidney injury in critically ill children - a developing country perspective.","volume":"37","author":"Rustagi","year":"2017","journal-title":"Paediatr Int Child Health"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jmii.2015.08.027","article-title":"Vancomycin dosing and target attainment in children.","volume":"50","author":"Hwang","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00431-015-2592-7","article-title":"Early fluid overload is associated with acute kidney injury and PICU mortality in critically ill children.","volume":"175","author":"Li","year":"2016","journal-title":"Eur J Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:54:37Z","timestamp":1694559277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002391","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}